EUDA Health (NASDAQ:EUDA) Cut to Strong Sell at Zacks Research

Zacks Research downgraded shares of EUDA Health (NASDAQ:EUDA) from a hold rating to a strong sell rating in a report issued on Monday morning,Zacks.com reports.

A number of other research firms have also issued reports on EUDA. Weiss Ratings reissued a “sell (d)” rating on shares of EUDA Health in a report on Friday, January 9th. Greenridge Global lowered their price objective on shares of EUDA Health from $120.00 to $55.00 and set a “buy” rating on the stock in a research report on Monday, March 9th. One equities research analyst has rated the stock with a Buy rating and two have issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Reduce” and a consensus price target of $55.00.

EUDA Health Stock Up 25.6%

EUDA opened at $11.47 on Monday. EUDA Health has a 52 week low of $6.42 and a 52 week high of $86.00. The business has a 50 day moving average price of $19.34 and a two-hundred day moving average price of $37.89. The company has a market cap of $21.68 million, a PE ratio of -95.58 and a beta of -0.11.

Institutional Investors Weigh In On EUDA Health

A hedge fund recently bought a new stake in EUDA Health stock. Jane Street Group LLC bought a new position in shares of EUDA Health Holdings Limited (NASDAQ:EUDA) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 25,675 shares of the company’s stock, valued at approximately $59,000. Jane Street Group LLC owned 0.07% of EUDA Health at the end of the most recent quarter. 4.35% of the stock is owned by institutional investors and hedge funds.

EUDA Health Company Profile

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.